India News | NTAGI Analyzes Data of COVID-19 Breakthrough Infections in India to Decide on Booster Dose

By Shalini Bhardwaj

New Delhi [India], December 14 (ANI): To make a decision regarding a booster dose of the COVID-19 vaccine, the National Technical Advisory Group on Immunisation (NTAGI) is analyzing data of COVID-19 breakthrough infections in India, said sources on Tuesday.

Also Read | India's Wholesale Price Inflation Rises to 14.23% in November 2021.

As per the sources, "NTAGI is analyzing data of COVID-19 breakthrough infections in India, to look at the vaccine effectiveness and take a decision regarding additional and booster dose."

During its last meeting, the NTAGI had made no final recommendation on additional COVID-19 vaccine doses and vaccines for children. However, both the issues were discussed in the meeting and the booster dose was not on the agenda of today's meeting. (ANI)

Also Read | Rachel Is Now Rajshri; Father Lalu Prasad Suggested the Name To Make It Easier for Bihar Natives To Pronounce, Says Tejashwi Yadav Post Wedding.

(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)